The mean age was 46 years (range 18 to 73), 81% were female, 84% were White, 13% were Black or African American, and 7% were Hispanic/Latino Ethnicity
Tesamorelin target visceral fat, the harmful fat surrounding internal organs, which is often resistant to traditional fat loss methods
The favorable results from the placebo-controlled FLOW trial, conducted with semaglutide 1.0 mg in patients with T2D and chronic kidney disesase (CKD), are about to be disclosed, while ongoing dedicated trials will further explore the effects of OW semaglutide 2.4 mg (NCT04889183) and tirzepatide (NCT05536804) on kidney function parameters in obese/overweight individuals at high risk of CKD progression regardless of T2D
It produced the highest weight loss seen in any phase 2 trial, up to 24% at the highest dose
"There has been significant widespread misinformation about an update to our anesthesia policy," Anthem BCBS said in a statement to ABC News
the sequence of events is poorly understood in the oral cavity